CHILDREN'S TYLENOL PLUS MULTI-SYMPTOM COLD OTC
Generic Name and Formulations:
Acetaminophen 160mg, chlorpheniramine maleate 1mg, dextromethorphan HBr 5mg, phenylephrine HCl 2.5mg; per 5mL; susp; grape flavor.
McNeil Consumer Healthcare
Indications for CHILDREN'S TYLENOL PLUS MULTI-SYMPTOM COLD:
Nasal congestion, rhinorrhea, sore throat, cough, headache, fever, minor aches and pains.
<4yrs (<36lbs): do not use. 4–5yrs (36lbs–47lbs): not recommended. 6–11yrs (48–95lbs): 10mL every 4 hours as needed; max 5 doses/24 hours.
Children <4yrs (<36lbs). During or within 14 days of MAOIs. Concomitant other acetaminophen products. For use as a sedative hypnotic.
Hepatic dysfunction. Cardiovascular disease. Hypertension. Thyroid disease. Glaucoma. GI or GU obstruction. Diabetes. Asthma. Lower respiratory disorders.
Analgesic + antihistamine + antitussive + sympathomimetic.
See Contraindications. Hypertensive crisis with MAOIs. β-blockers may increase pressor effects of sympathomimetics. Antihypertensives antagonized. Increased CNS effects with other CNS depressants.
Drowsiness, anticholinergic effects, nervousness, dizziness, insomnia, excitability, hepatotoxicity (overdosage).
Endocrinology Advisor Articles
- Cushing Syndrome Results in Poor Quality of Life Even After Remission
- DPP-4 Inhibitors and Incidence of Rheumatoid Arthritis in Type 2 Diabetes
- Cost-Benefit Analysis of Insulin Analogs in Type 2 Diabetes
- Low Predictive Power of Biomarkers for Estimated Glomerular Filtration Rate Decline
- Predictors of Weight Loss in Postpartum Women With Gestational Diabetes
- Nutraceuticals May Benefit Patients Who Are Statin Intolerant
- Link Between Gestational Diabetes and Risk for CVD and Diabetes in Hispanic/Latina Population
- Clinical Characteristics Altering Risks and Benefits of Sulfonylureas and Thiazolidinedione Therapy in T2D
- 6 Factors Related to Inclusion in Health Care Workplace Identified
- Weight Gain After Quitting Smoking May Increase Risk for T2D